Candesartan seems to be effective and well tolerated in preventing episodic migraine in adults, a phase 2 trial shows.

AbbVie (NYSE: ABBV) announced today that the RAMQ has listed QULIPTA® in their formulary for the prevention of chronic migraine and episodic migraine.i This will be followed by reimbursement by ...

Caffeine can both relieve and trigger headaches, and its effect varies from person to person. Learn more about the connection ...

Migraine is a spectrum disorder with many manifestations. Understand the official classifications of migraine types, including hemiplegic migraine and retinal migraine, to better manage your condition ...

US President Donald Trump on Monday claimed that using acetaminophen or Tylenol (known in Australia as paracetamol) during ...

Lundbeck demonstrates leadership and unwavering commitment to advancing migraine management and supporting patient outcomes ...

Over the past decade, migraine has received more attention than ever with the advancement of migraine-specific drugs.

As interest waned and episodic releases became more sporadic, the company’s reputation soured — and by their closure in 2018, multiple games including the follow-ups to Game of Thrones and The Wolf ...

GammaCore is an FDA-cleared, handheld device that uses noninvasive vagus nerve stimulation to treat and prevent migraine attacks and cluster headaches. Learn how the device works, how to get one, and ...

This clinical case of a 58-year-old man experiencing "rushes of anxiety" demonstrates the paroxysmal nature of pheochromocytoma symptoms.

Vagus Nerve Stimulation (VNS) Devices, valued at USD 35 million in 2024, are expanding in clinical adoption, particularly in ...